Hyewon Ko Selected Research

carboxymethyl dextran

4/2018	Carboxymethyl dextran-based hypoxia-responsive nanoparticles for doxorubicin delivery.
1/2018	A carboxymethyl dextran-based polymeric conjugate as the antigen carrier for cancer immunotherapy.
5/2016	A pH-responsive carboxymethyl dextran-based conjugate as a carrier of docetaxel for cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hyewon Ko Research Topics

Disease

23	Neoplasms (Cancer) 01/2022 - 06/2013
1	Experimental Arthritis 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Rheumatoid Arthritis 01/2021
1	Necrosis 04/2020
1	Hypophysitis 01/2019
1	Liver Diseases (Liver Disease) 01/2019
1	Triple Negative Breast Neoplasms 04/2018
1	Hypoxia (Hypoxemia) 04/2018

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 01/2019 - 06/2013
5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 06/2013
4	Drug CarriersIBA 11/2019 - 02/2015
4	GoldIBA 10/2018 - 12/2015
4	Hyaluronic Acid (Hyaluronan)IBA 01/2016 - 06/2013
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 10/2016
3	carboxymethyl dextranIBA 04/2018 - 05/2016
2	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2020
2	Ethylene Glycol (Monoethylene Glycol)IBA 11/2018 - 06/2013
2	DisulfidesIBA 04/2018 - 02/2015
2	PolymersIBA 04/2018 - 04/2016
2	MicellesIBA 10/2016 - 02/2015
1	SulfonamidesIBA 01/2022
1	Sulfisoxazole (Sulfafurazole)FDA Link 01/2022
1	Endothelin Receptor AntagonistsIBA 01/2021
1	macitentanIBA 01/2021
1	EnzymesIBA 04/2020
1	CaspasesIBA 04/2020
1	Protein Kinases (Protein Kinase)IBA 04/2020
1	Cytotoxins (Cytolysins)IBA 01/2019
1	Dextrans (Dextran)FDA Link 11/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2018
1	Vasodilator Agents (Vasodilators)IBA 11/2018
1	EstersIBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	Glycoproteins (Glycoprotein)IBA 04/2018
1	Stimuli Responsive PolymersIBA 01/2018
1	OvalbuminIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	AntigensIBA 01/2018
1	Histocompatibility Antigens Class IIBA 01/2018
1	AutoantigensIBA 01/2018
1	glycol-chitosanIBA 12/2017
1	Docetaxel (Taxotere)FDA Link 05/2016
1	BuffersIBA 05/2016
1	Small Interfering RNA (siRNA)IBA 12/2015
1	polycaprolactoneIBA 02/2015
1	Phosphates (Orthophosphate)IBA 06/2013
1	CalciumIBA 06/2013
1	IonsIBA 06/2013

Therapy/Procedure

15	Therapeutics 01/2021 - 02/2015
3	Immunotherapy 04/2020 - 01/2018
1	Intravenous Administration 01/2021
1	Drug Therapy (Chemotherapy) 01/2018
1	Precision Medicine 12/2017